Drugs made of mRNA have the potential to transform medicine—if only they could get into cells in one piece. Now, University ...

Messenger RNA (mRNA) technology is transforming medicine by providing our cells with genetic instructions to produce proteins ...

Update: The FDA reversed its decision on Feb. 18 and agreed to consider Moderna's application. Read the latest here. Our earlier story is below. The Food and Drug Administration is refusing to ...

The Food and Drug Administration has refused to review Moderna’s application for an mRNA flu vaccine, the company revealed Tuesday. While the move came as a surprise to the high-profile vaccine maker, ...

CNBC's Kelly Evans reports on the latest news. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your ...

CNBC's Kelly Evans reports on the latest news. Woman pulls up home, horse immediately tells her “something is off” Archaeologists discovered hidden messages in the likely room of Jesus’s last supper ...

Pharma stock Moderna (MRNA) is experiencing a sharp pullback from its Jan. 22, 52-week high of $55.20. Last seen down 3.5% at $39.08, the shares are headed for their third-straight weekly loss. For ...

During the first year of the Trump administration, signs of an anti-mRNA slant within the FDA and the Department of Health and Human Services (HHS) became more and more evident. Now, with a refusal-to ...

The brain’s ability to do everything from forming memories to coordinating movement relies on its cells producing the right proteins at the right time. But directly measuring this protein production, ...